Your browser doesn't support javascript.
loading
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.
Passaro, A; Leighl, N; Blackhall, F; Popat, S; Kerr, K; Ahn, M J; Arcila, M E; Arrieta, O; Planchard, D; de Marinis, F; Dingemans, A M; Dziadziuszko, R; Faivre-Finn, C; Feldman, J; Felip, E; Curigliano, G; Herbst, R; Jänne, P A; John, T; Mitsudomi, T; Mok, T; Normanno, N; Paz-Ares, L; Ramalingam, S; Sequist, L; Vansteenkiste, J; Wistuba, I I; Wolf, J; Wu, Y L; Yang, S R; Yang, J C H; Yatabe, Y; Pentheroudakis, G; Peters, S.
Afiliación
  • Passaro A; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: antonio.passaro@ieo.it.
  • Leighl N; Division of Medical Oncology/Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Canada.
  • Blackhall F; Division of Cancer Sciences, The University of Manchester, Manchester, UK; Department of Medical Oncology, The Christie National Health Service (NHS) Foundation Trust, Manchester, UK.
  • Popat S; National Heart and Lung Institute, Imperial College, London, UK; Lung Unit, Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK.
  • Kerr K; Aberdeen Royal Infirmary, Aberdeen University Medical School, Aberdeen, UK.
  • Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Arcila ME; Department of Pathology, Molecular Diagnostics Service, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Arrieta O; Thoracic Oncology Unit, Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Planchard D; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • de Marinis F; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy.
  • Dingemans AM; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Dziadziuszko R; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
  • Faivre-Finn C; The University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK.
  • Feldman J; Lung Cancer Patient and Advocate, Co-Founder of EGFR Resisters Patient Group.
  • Felip E; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Curigliano G; Department of Oncology and Hemato-Oncology, University of Milano, European Institute of Oncology IRCCS, Milan, Italy.
  • Herbst R; Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, USA.
  • Jänne PA; Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • John T; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Mitsudomi T; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Mok T; State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, Hong Kong, China.
  • Normanno N; Cell Biology and Biotherapy and Scientific Directorate, Istituto Nazionale Tumori, "Fondazione G.Pascale" IRCCS, Naples, Italy.
  • Paz-Ares L; Lung Cancer Clinical Research Unit, and Complutense University, Madrid, Spain.
  • Ramalingam S; Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, Georgia.
  • Sequist L; Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Vansteenkiste J; Department of Respiratory Oncology, University Hospital KU Leuven, Leuven, Belgium.
  • Wistuba II; Department of Translational Molecular Pathology, Unit 951, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Wolf J; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangdong, China.
  • Yang SR; The Institute of Cancer Research, London, UK.
  • Yang JCH; Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Republic of China.
  • Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
  • Pentheroudakis G; Department of Medical Oncology, University of Ioannina, Ioannina, Epirus, Greece.
  • Peters S; Oncology Department - CHUV, Lausanne University, Lausanne, Switzerland.
Ann Oncol ; 33(5): 466-487, 2022 05.
Article en En | MEDLINE | ID: mdl-35176458
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido